{"organizations": [], "uuid": "6f47210c58a91cf57c8985e9bbb158601f1da569", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "http://si.wsj.net/img/WSJ_Logo_black_social.gif", "site_section": "http://www.wsj.com/news/markets", "section_title": "Stock Market &amp; Finance News - Wall Street Journal", "url": "http://www.wsj.com/articles/lannett-to-acquire-ucbs-kremers-urban-pharmaceuticals-unit-for-1-23-billion-1441228664", "country": "US", "title": "Lannett to Acquire UCB’s Kremers Urban Pharmaceuticals Unit for $1.23 Billion", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "Lannett to Acquire UCB’s Kremers Urban Pharmaceuticals Unit for $1.23 Billion - WSJ", "spam_score": 0.0, "site_type": "news", "published": "2015-09-03T01:17:00.000+03:00", "replies_count": 0, "uuid": "6f47210c58a91cf57c8985e9bbb158601f1da569"}, "author": "Maria Armental", "url": "http://www.wsj.com/articles/lannett-to-acquire-ucbs-kremers-urban-pharmaceuticals-unit-for-1-23-billion-1441228664", "ord_in_thread": 0, "title": "Lannett to Acquire UCB’s Kremers Urban Pharmaceuticals Unit for $1.23 Billion", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Lannett Co. Inc. has agreed to buy UCB SA’s Kremers Urban Pharmaceuticals Inc. for $1.23 billion.\nThe deal, expected to close in the fourth quarter, also calls for potential contingency payments under sales and timing thresholds.\nLannett, which said it is borrowing up to $1.29 billion to pay for the acquisition, estimated a mid- to... ", "external_links": [], "published": "2015-09-03T01:17:00.000+03:00", "crawled": "2015-09-03T00:40:31.067+03:00", "highlightTitle": ""}